These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 27428326)

  • 1. Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells.
    Yue Q; Zhen H; Huang M; Zheng X; Feng L; Jiang B; Yang M; Wu W; Liu X; Guo D
    PLoS One; 2016; 11(7):e0159034. PubMed ID: 27428326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bufadienolides from amphibians: A promising source of anticancer prototypes for radical innovation, apoptosis triggering and Na
    Sousa LQ; Machado KD; Oliveira SF; Araújo LD; Monção-Filho ED; Melo-Cavalcante AA; Vieira-Júnior GM; Ferreira PM
    Toxicon; 2017 Mar; 127():63-76. PubMed ID: 28069354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bufadienolides from parotoid gland secretions of Cuban toad Peltophryne fustiger (Bufonidae): Inhibition of human kidney Na(+)/K(+)-ATPase activity.
    Perera Córdova WH; Leitão SG; Cunha-Filho G; Bosch RA; Alonso IP; Pereda-Miranda R; Gervou R; Touza NA; Quintas LE; Noël F
    Toxicon; 2016 Feb; 110():27-34. PubMed ID: 26615828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
    Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New bufadienolides extracted from Rhinella marina inhibit Na,K-ATPase and induce apoptosis by activating caspases 3 and 9 in human breast and ovarian cancer cells.
    Garcia IJP; de Oliveira GC; de Moura Valadares JM; Banfi FF; Andrade SN; Freitas TR; Dos Santos Monção Filho E; Lima Santos H; Júnior GMV; Chaves MH; de Jesus Rodrigues D; Sanchez BAM; Varotti FP; Barbosa LA
    Steroids; 2019 Dec; 152():108490. PubMed ID: 31499071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arenobufagin, isolated from toad venom, inhibited epithelial-to-mesenchymal transition and suppressed migration and invasion of lung cancer cells via targeting IKKβ/NFκB signal cascade.
    Zhao J; Zhang Q; Zou G; Gao G; Yue Q
    J Ethnopharmacol; 2020 Mar; 250():112492. PubMed ID: 31866511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arenobufagin, a compound in toad venom, blocks Na(+)-K+ pump current in cardiac myocytes.
    Cruz Jdos S; Matsuda H
    Eur J Pharmacol; 1993 Aug; 239(1-3):223-6. PubMed ID: 8223897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C23 steroids from the venom of Bufo bufo gargarizans.
    Tian HY; Luo SL; Liu JS; Wang L; Wang Y; Zhang DM; Zhang XQ; Jiang RW; Ye WC
    J Nat Prod; 2013 Oct; 76(10):1842-7. PubMed ID: 24050254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arenobufagin Induces Apoptotic Cell Death in Human Non-Small-Cell Lung Cancer Cells via the Noxa-Related Pathway.
    Ma L; Zhu Y; Fang S; Long H; Liu X; Liu Z
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28892004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity of cardiotonic steroids in sensitive and multidrug-resistant leukemia cells and the link with Na(+)/K(+)-ATPase.
    Zeino M; Brenk R; Gruber L; Zehl M; Urban E; Kopp B; Efferth T
    J Steroid Biochem Mol Biol; 2015 Jun; 150():97-111. PubMed ID: 25797029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway.
    Li M; Wu S; Liu Z; Zhang W; Xu J; Wang Y; Liu J; Zhang D; Tian H; Li Y; Ye W
    Biochem Pharmacol; 2012 May; 83(9):1251-60. PubMed ID: 22305746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive effects of arenobufagin on the delayed rectifier K+ current of guinea-pig cardiac myocytes.
    Cruz Jdos S; Matsuda H
    Eur J Pharmacol; 1994 Feb; 266(3):317-25. PubMed ID: 8174614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toad venom bufadienolides and bufotoxins: An updated review.
    Asrorov AM; Kayumov M; Mukhamedov N; Yashinov A; Mirakhmetova Z; Huang Y; Yili A; Aisa HA; Tashmukhamedov M; Salikhov S; Mirzaakhmedov S
    Drug Dev Res; 2023 Aug; 84(5):815-838. PubMed ID: 37154099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bufalin inhibits glioblastoma growth by promoting proteasomal degradation of the Na
    Lan YL; Wang X; Lou JC; Xing JS; Yu ZL; Wang H; Zou S; Ma X; Zhang B
    Biomed Pharmacother; 2018 Jul; 103():204-215. PubMed ID: 29653366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.
    Deng LJ; Peng QL; Wang LH; Xu J; Liu JS; Li YJ; Zhuo ZJ; Bai LL; Hu LP; Chen WM; Ye WC; Zhang DM
    Oncotarget; 2015 Oct; 6(33):34258-75. PubMed ID: 26485758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bufadienolides from the Bufo viridis toad venom exert cytotoxic effects on cancer cells by inducing cell apoptosis and cell cycle arrest.
    Dong Q; Turdu G; Dongmulati N; Maimaitijang A; Aisa HA; Yili A
    Toxicol In Vitro; 2023 Jun; 89():105566. PubMed ID: 36738868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spin-labeled derivatives of cardiotonic steroids as tools for characterization of the extracellular entrance to the binding site on Na
    Guo JH; Jiang RW; Andersen JL; Esmann M; Fedosova NU
    FEBS J; 2018 Jun; 285(12):2292-2305. PubMed ID: 29688626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γ-Benzylidene digoxin derivatives synthesis and molecular modeling: Evaluation of anticancer and the Na,K-ATPase activity effect.
    Alves SLG; Paixão N; Ferreira LGR; Santos FRS; Neves LDR; Oliveira GC; Cortes VF; Salomé KS; Barison A; Santos FV; Cenzi G; Varotti FP; Oliveira SMF; Taranto AG; Comar M; Silva LM; Noël F; Quintas LEM; Barbosa LA; Villar JAFP
    Bioorg Med Chem; 2015 Aug; 23(15):4397-4404. PubMed ID: 26122772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Na
    Medina-Ortiz K; López-Alvarez D; Navia F; Hansen T; Fierro L; Castaño S
    Comp Biochem Physiol A Mol Integr Physiol; 2021 Apr; 254():110906. PubMed ID: 33476762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Na⁺/K⁺ -translocating adenosine triphosphatase in cancer treatment.
    Durlacher CT; Chow K; Chen XW; He ZX; Zhang X; Yang T; Zhou SF
    Clin Exp Pharmacol Physiol; 2015 May; 42(5):427-43. PubMed ID: 25739707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.